Patents by Inventor R. Amour Forse

R. Amour Forse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5821217
    Abstract: An improved enteral formulation that is low in fat and contains protein hydrolysates has been developed. The osmolality of the formulation is controlled to be below 500 mOs/kg H.sub.2 O, preferably about 300 mOs/kg H.sub.2 O. In a preferred embodiment, the formulation contains corn starch to control blood glucose levels. This formulation is particularly useful for treatment of critically ill patients and in minimizing a risk of pulmonary aspiration and/or gastrointestinal dysfunction in such patients.
    Type: Grant
    Filed: October 27, 1995
    Date of Patent: October 13, 1998
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: R. Amour Forse, Stacey J. Bell, Peter Burke
  • Patent number: 5386832
    Abstract: A test for determining hepatic function has been developed. This test uses oral administration of isotope labeled phenylalanine or tyrosine, particularly .sup.13 C-phenylalanine, in a rapid breath test. In the preferred mode, the breath sample is analyzed using a mass spectrometer and compared with a standard. The breath test provides a dynamic rather than static determination of hepatic function and can be used for both early and late stage liver problems.
    Type: Grant
    Filed: June 11, 1993
    Date of Patent: February 7, 1995
    Assignees: New England Deaconess Hospital, Metabolics Solutions, Inc.
    Inventors: David A. Wagner, Martin A. Baker, Peter A. Burke, R. Amour Forse, John D. Palombo, Bruce R. Bistrian